Coronavirus: Tracking India's coronavirus vaccine progress

The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. 

The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. The target is to procure between 400 and 500 million vaccine doses on equitable access basis. But are we any closer to a vaccine? Let's find out

The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. The target is to procure between 400 and 500 million vaccine doses on equitable access basis. But are we any closer to a vaccine? Let's find out

Vaccine 1: Covishield Company: Serum Insititute of India Number of volunteers: 1600 Status of trial: Phase 3 ongoing Type of vaccine: Non-replicating viral vector (chimp adenovirus)

Vaccine 1: Covishield
Company: Serum Insititute of India
Number of volunteers: 1600
Status of trial: Phase 3 ongoing
Type of vaccine: Non-replicating viral vector (chimp adenovirus)

Vaccine 2: Sputnik V Company: Dr Reddy's + Gamaleya Research Institute Number of volunteers: 76 Status of trial: Permission sought for phase 3 Type of vaccine: Non-replicating viral vector (human adenovirus)

Vaccine 2: Sputnik V
Company: Dr Reddy's + Gamaleya Research Institute
Number of volunteers: 76
Status of trial: Permission sought for phase 3
Type of vaccine: Non-replicating viral vector (human adenovirus)

Vaccine 3: Covaxin Company: Bharat Biotech Number of volunteers: 1125 Status of trial: Phase 2 ongoing Type of vaccine: Whole virion inactivated vaccine

Vaccine 3: Covaxin
Company: Bharat Biotech
Number of volunteers: 1125
Status of trial: Phase 2 ongoing
Type of vaccine: Whole virion inactivated vaccine

Vaccine 4: ZyCov-D Company: Zydus Cadila Number of volunteers: 1048 Status of trial: Phase 2 ongoing Type of vaccine: Plasmid DNA  

Vaccine 4: ZyCov-D
Company: Zydus Cadila
Number of volunteers: 1048
Status of trial: Phase 2 ongoing
Type of vaccine: Plasmid DNA

Vaccine 5: RBD Vaccine Company: Biologicale + Baylor College of Medicine Number of volunteers: 400 Status of trial: Permission sought for phase 3 Type of vaccine: Recombinant protein vaccine

Vaccine 5: RBD Vaccine
Company: Biologicale + Baylor College of Medicine
Number of volunteers: 400
Status of trial: Permission sought for phase 3
Type of vaccine: Recombinant protein vaccine